Skip to main content
Clinical Trials/NCT04805645
NCT04805645
Terminated
Not Applicable

Clinical Characteristics & Risk Factors for Mortality of COVID-19 Patients Admitted Into Intensive Care Unit in Hospital Queen Elizabeth

Clinical Research Centre, Malaysia1 site in 1 country50 target enrollmentApril 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Covid19
Sponsor
Clinical Research Centre, Malaysia
Enrollment
50
Locations
1
Primary Endpoint
Mortality
Status
Terminated
Last Updated
2 years ago

Overview

Brief Summary

Studying clinical characterization of critically ill COVID-19 patients in a single center Studying Risk factors for Day 28 Mortality in COVID-19 patients admitted to intensive care unit

Detailed Description

An observational study looking into clinical characterization of the novel Coronavirus Disease 2019 (COVID-19) in patients admitted, critically ill, into Intensive Care Unit of Hospital Queen Elizabeth between 1st October 2020 until 31st January 2021. Analysis also would be looking into the risk factors into Day 28 mortality of these patients

Registry
clinicaltrials.gov
Start Date
April 1, 2021
End Date
May 1, 2021
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Clinical Research Centre, Malaysia
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All patients admitted to the ICU in Hospital Queen Elizabeth, Kota Kinabalu between 1st October 2020 until 31st January 2021
  • Confirmed COVID-19 Positive using RT-PCR or RTK-Ag either before or during admission in ICU

Exclusion Criteria

  • Patients that were admitted in ICU suspected to have COVID-19 and died in ICU which subsequently to be COVID-19 negative

Outcomes

Primary Outcomes

Mortality

Time Frame: 28 days

Died before or on Day 28 after ICU admission

Secondary Outcomes

  • Oxygen supplementation requirement(day 28)

Study Sites (1)

Loading locations...

Similar Trials